Guidelines for standardizing T-cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetes.
Saved in:
| Title: | Guidelines for standardizing T-cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetes. |
|---|---|
| Authors: | Yang JHM; Department of Immunobiology, Faculty of Life Sciences & Medicine, King's College, London, UK.; National Institute of Health Research Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust, King's College London, London, UK., Ward-Hartstonge KA; Department of Surgery, University of British Columbia, Vancouver, California, USA.; BC Children's Hospital Research Institute, Vancouver, California, USA., Perry DJ; Department of Pathology, Immunology, and Laboratory Medicine, University of Florida Diabetes Institute, Gainesville, Florida, USA., Blanchfield JL; Center for Translational Research, Benaroya Research Institute, Seattle, Washington, USA., Posgai AL; Department of Pathology, Immunology, and Laboratory Medicine, University of Florida Diabetes Institute, Gainesville, Florida, USA., Wiedeman AE; Center for Translational Research, Benaroya Research Institute, Seattle, Washington, USA., Diggins K; Center for Translational Research, Benaroya Research Institute, Seattle, Washington, USA., Rahman A; Human Immune Monitoring Center, Hess Center for Science and Medicine, Icahn School of Medicine, New York, New York, USA., Tree TIM; Department of Immunobiology, Faculty of Life Sciences & Medicine, King's College, London, UK.; National Institute of Health Research Biomedical Research Centre at Guy's and St. Thomas' National Health Service Foundation Trust, King's College London, London, UK., Brusko TM; Department of Pathology, Immunology, and Laboratory Medicine, University of Florida Diabetes Institute, Gainesville, Florida, USA.; Department of Pediatrics, University of Florida Diabetes Institute, Gainesville, FL, USA., Levings MK; Department of Surgery, University of British Columbia, Vancouver, California, USA.; BC Children's Hospital Research Institute, Vancouver, California, USA.; School of Biomedical Engineering, University of British Columbia, California, USA., James EA; Center for Translational Research, Benaroya Research Institute, Seattle, Washington, USA., Kent SC; Diabetes Center of Excellence, University of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA., Speake C; Center for Interventional Immunology, Benaroya Research Institute, Seattle, Washington, USA., Homann D; Precision Immunology Institute, Icahn School of Medicine, New York, New York, USA.; Diabetes, Obesity, & Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Long SA; Center for Translational Research, Benaroya Research Institute, Seattle, Washington, USA. |
| Corporate Authors: | Immunology of Diabetes Society T-Cell Cytometry Group |
| Source: | European journal of immunology [Eur J Immunol] 2022 Mar; Vol. 52 (3), pp. 372-388. Date of Electronic Publication: 2022 Jan 28. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4141 (Electronic) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1521-4141 |
|---|---|
| DOI: | 10.1002/eji.202049067 |
